Composition of the multiple antithrombotic therapy group.
收藏数据链接：
官方服务：
资源简介：
Composition of the multiple antithrombotic therapy group.
应用场景：
创建时间：
2021-01-07
相关数据集
未使用血栓溶解劑治療之缺血性腦中風病人住院一日內給予抗血栓藥治療之比率
急性缺血性腦中風發生後 48 小時內，給予口服較高初始劑量的抗血栓藥物，可顯著地減少死亡率以及不良預後，好處是減少了早期腦中風復發；證據也顯示急性輕微缺血性腦中風或高風險的暫時性腦缺血個案，短期合併使用抗血栓藥物，可以減少腦中風復發，且不會增加出血及重大事件發生率。
台湾省政府资料开放平台2025-12-09 更新90
COVID-19 ACTIV-4 ACUTE: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)
This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients.
DataCite Commons2026-04-09 更新60
Supplementary Material for: Antithrombotic Management in Adult Kidney Transplantation – A European survey study
In kidney transplantation (KTx), renal graft thrombosis (RGT) is one of the main reasons for early graft loss. Although evidence-based guidance on prevention of RGT is lacking, thromboprophylaxis is w
karger.figshare.com2023-06-02 更新30
Supplementary Material for: Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single Center Retrospective Study
Introduction: To investigate the risk factors of tigecycline-induced hypofibrinogenemia, and to evaluate the safety of tigecycline with concomitant antithrombotic drugs. Methods: We performed a retros
DataCite Commons2025-05-01 更新60
Supplementary Material for: Half-dose anticoagulation versus antiplatelet therapy to reduce silent cerebral embolism after left atrial appendage occlusion (HALO-SCE study): Rationale and design of a randomized clinical trial
Introduction: Patients with atrial fibrillation (AF) continue to face thrombotic risks even after the left atrial appendages (LAA) have been occluded, which may manifest as silent cerebral embolisms (
DataCite Commons2025-07-14 更新50
